In view of a recent spread of severe acute respiratory syndrome (SARS), there is a high demand for production of a vaccine to prevent this disease. Recent studies indicate that SARS-coronavirus (CoV) spike protein (S protein) and its truncated fragments are considered the best candidates for generation of the recombinant vaccine. Toward the development of a safe, effective, and inexpensive vaccine candidate, we have expressed the N-terminal fragment of SARS-CoV S protein (S1) in tomato and low-nicotine tobacco plants. Incorporation of the S1 fragment into plant genomes as well as its transcription was confirmed by PCR and RT-PCR analyses. High levels of expression of recombinant S1 protein were observed in several transgenic lines by Western blot analysis using specific antibodies. Plant-derived antigen was evaluated to induce the systemic and mucosal immune responses in mice. Mice showed significantly increased levels of SARS-CoV-specific IgA after oral ingestion of tomato fruits expressing S1 protein. Sera of mice parenterally primed with tobacco-derived S1 protein revealed the presence of SARS-CoV-specific IgG as detected by Western blot and ELISA analysis.
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immune response ͉ plant biotechnology ͉ severe acute respiratory syndrome-coronavirus ͉ recombinant subunit vaccine T he recent spread of severe acute respiratory syndrome (SARS) has heightened demand for a SARS vaccine that is safe, effective, economical, and easily administered. The production of recombinant subunit vaccines has become a valuable modern strategy for prevention of infectious diseases (1, 2) . Development of such vaccines relies on the identification of the best antigen and the choice of expression system.
The causative agent of SARS has been identified as SARScoronavirus (CoV) (3) (4) (5) , which is similar to other CoVs in both virion structure and genomic organization (5, 6) . Efforts to develop a vaccine against SARS are necessarily based on only the limited knowledge gained from studies of SARS-CoV, as well as on anti-CoV strategies that have been devised over the years. Several groups have shown that the spike glycoproteins are major inducers of neutralizing antibodies, providing protective immunity against many CoVs (7) (8) (9) (10) (11) . Currently, the SARS-CoV S glycoprotein and its truncated versions are considered the best candidates for generation of a recombinant vaccine against this disease (12) (13) (14) (15) (16) (17) (18) (19) (20) . The full-length SARS-CoV spike protein (S protein) is large (139 kDa) and probably not cleaved into S1 and S2 subunits (21, 22) . The N-terminal part of the SARS-CoV S protein (S1) contains a putative receptor-binding domain (RBD) that is responsible for cell attachment (15, 23) . Antibodies against this region were found to be highly effective in blocking RBD-receptor interaction in other CoVs (24) . Moreover, vaccinated animals developed an antibody response against the S1 fragment of SARS S protein (25) , and SARS patient sera showed significant immunoreactivity with peptide located within the S1 region (19) .
Recent studies have shown that the plant system provides many practical, economic, and safety advantages compared with conventional systems for production and convenient delivery of the subunit vaccines (26) (27) (28) (29) (30) . Particularly, it is true for mucosal surfaces that could provide a safe method for inducing protective immune responses without injection-related hazards (31) . Several groups have reported development of S protein recombinant plant-based vaccines against different CoVs for oral delivery that elicit protective immunity against virus challenge (9) (10) (11) 32) . Recently, a S protein plant-based vaccine candidate against swine transmissible gastroenteritis CoV has advanced into early phase farming trials (11) . The neutralizing response in chickens immunized orally with transgenic potato expressing S1 protein of another CoV (infectious bronchitis virus) was comparable to that observed with the commercial vaccine against this disease (9) .
In this study, we report the successful expression of the S1 fragment of the SARS-CoV S protein in transgenic tomato and low-nicotine tobacco plants and demonstrate its immunogenicity in mice after parenteral or oral administration.
Materials and Methods

Cloning of the SARS-CoV Spike Gene into the Plant Transformation
Vector. The original gene encoding the human SARS-CoV spike glycoprotein (strain TOR2, National Center for Biotechnology Information no. NC 004718) is 3,768-bp long, encodes a protein of 1,255 aa with a molecular mass of 139 kDa, and was kindly provided by I. Lipkin (Columbia University, New York). DNA encoding a 79-kDa S protein fragment, corresponding to amino acids 14-714, was amplified by two consecutive rounds of PCR to generate XbaI and SacI sites at the 5Ј and 3Ј ends, respectively, by using the following primers: SP-F1-CCT TGC GCT TCT CAG CCA CGC  AAA CTC AAG AGG ATC GCA TCA CCA TCA CCA TCA  CAG TGA CCT TGA CCG GTG CAC, XbaI-F2-ATA ATC TAG  ATG ATC ATG GCT TCC TCC AAG TTA CTC TCC CTA GCC  CTC TTC CTT GCG CTT CTC AGC CAC G, and SacI-HDEL-R-ATT CGA GCT CTT AAA GTT CAT CAT GAG CCA TAG AAA CAG GCA TTA CT. The expression cassette of SARS-CoV S1 protein comprised the plant-derived 23-aa {MIMASSKLLS-LALFLALLSHANS}, signal peptide (SP), and a histidine tag {RGSHHHHHH} at the N-terminal portion of the resulting 79-kDa polypeptide. After addition of the plant-specific endoplasmic reticulum retention signal {HDEL}, the cassette was subcloned into the XbaI͞SacI site of the plant binary vector pE1801 (kindly provided by S. Gelvin, Purdue University, West Lafayette, IN) under synthetic (OCS) 3 MAS promoter (33) , which is known as a super promoter, followed by a tomato etch virus translation enhancer. Vector also contains the npt II gene for kanamycin selection of transgenic plants. Plasmid pE1801-79S HDEL was electroporated into Agrobacterium tumefaciens strain LBA4404 and used for plant transformations. Proteins were purified by using magnetic beads (following the protocol of the manufacturer, Dynal, Oslo) mixed with Laemmli buffer and heated and resolved on 4-20% gradient SDS͞PAGE. Following the electroblotting procedure, proteins were detected with SARS S protein-specific rabbit antibodies Sm and͞or Sn (catalog nos. AP600b and AP6000a, respectively, Abgent, San Diego) at 1͞1,000 dilution or with mouse sera (see below) at 1͞500 dilution and the corresponding horseradish peroxidase-conjugated anti-rabbit or anti-mouse antibodies at 1͞10,000 dilution. Baculovirus expressed the full-length 139-kDa S protein (catalog no. 06450, Protein Science, Meriden, CT) and was used as a positive control.
A freeze-dry lyophilizer system (VirTis, Gardner, NY) was used to obtain lyophilized tobacco root and tomato fruit tissues. Tissues were ground in liquid nitrogen and homogenized in extraction buffer (50 mM Tris⅐Cl͞150 mM NaCl͞2% Nonidet P-40͞1% desoxycholic acid͞0.5% SDS) at pH 8.0 with complete protease inhibitor mixture (Roche Applied Science, Indianapolis) for SDS͞ PAGE and Western blot analysis at 50 g per lane of total soluble protein.
Immunological Assessment of Plant-Expressed S Protein in Mice.
Groups of 6-to 8-week-old female BALB͞c mice (five mice per group) were used in all experiments. For oral immunization experiments, mice were either fed lyophilized tissue material of ripened tomato fruits or received powdered low-alkaloid tobacco root material reconstituted in saline by gastric intubation (g.i.). Each mouse consumed Ϸ500 mg of dry tomato fruit tissue over a period of 4-5 h. Intubated mice each received the equivalent of 50 mg of dry tobacco root material. Control groups of mice received the same amount of WT plant material. Blood and fecal pellets were collected. Fecal pellets were extracted with 10 volumes of PBS immediately after collection. Sera and fecal pellet extracts were assayed for the presence of antigen-specific antibodies by Western blot analysis and ELISA.
For parenteral immunization, mice were injected three times at 2-week intervals with an equivalent of 50 mg of dry tobacco root material per mouse. Powdered plant material was reconstituted with saline (1͞1 by weight) just before immunization. First and second immunizations were given s.c. with complete and incomplete Freund's adjuvant, respectively; the third dose was administered i.p. in saline. Sera were collected retroorbitally from each mouse before and 10 days after each immunization. Four weeks after the last immunization, mice received an i.p. booster dose of 1 g of commercially obtained S peptide (Cell Sciences, Canton, MA) without adjuvant. After 10 days, mice were killed and exanguinated by heart puncture, and sera were assayed by ELISA and Western blot analysis.
Solid-phase ELISA was carried out as described in ref. 37 in MaxiSorp 96-well plates (Nalge Nunc) coated overnight at 4°C with the same S peptides obtained from Cell Sciences at a concentration of 1 g͞ml in PBS. Antigen-specific antibodies were detected by using the following antibodies: rabbit anti-mouse IgG (total) and anti-mouse IgG1 (both from BD Biosciences Pharmingen), anti- mouse IgG2a, IgG2b, IgG3, IgM, and IgA (all from Organon Teknika), and anti-mouse IgE (eBioscience, San Diego). A serum dilution with an OD 450 of 0.15 units above background was considered the ELISA titer.
Results
Construction of Expression Vectors.
The construct for plant transformation contained the 2.2-kb fragment of the SARS-CoV spike gene encoding the truncated 79-kDa S1 region of the 139-kDa S protein within the T-DNA of the pBI-based plant transformation vector pE1801 under the strong (OCS) 3 MAS promoter. We substituted the viral SP (1-13 aa) of the original spike gene with the plant-derived SP at the N terminus and added a plant-specific HDEL endoplasmic reticulum retention signal at the C terminus of the 14-to 714-aa S fragment (see Fig. 1A ). The resulting plant transformation construct pE1801-79S HDEL also contains the npt II gene for selection of transgenic plants on kanamycin-supplemented medium. The same 79-kDa version and the shorter 53-kDa version of truncated SARS-CoV spike gene were also used for E. coli expression and verification analysis with S-specific antibodies Sn and Sm (Fig. 1B) , which recognize two distinct parts of the S protein. Transgene expression levels were analyzed by quantitative RT-PCR. As expected, mRNA expression levels varied among independent transgenic lines. Fig. 3B shows the detailed analysis of transgenic tobacco plants. For some transgenic lines (lane 18 for low-nicotine tobacco cv. LAMD-609 and lane 12 for control tobacco cv. Wisconsin), expression levels reached 10 5 -10 6 copies of S protein transcript per 50 ng of total cDNA. mRNA levels in leaves and roots of the same transgenic lines consistently revealed higher levels of expression in the roots (see Fig. 3B Lower, for example) .
Production of Transgenic Plants Expressing
Western blot analysis of transgenic lines with polyclonal SARSspecific antibodies Sm and Sn confirmed the presence of SARSCoV S-specific 79-kDa protein and its derivatives at variable levels (Figs. 2B and 3 C and D) . The 79-kDa protein was barely detectable in several green tomato fruits but was highly expressed in others (compare lanes 2 and 4 in Fig. 2B Upper Right) . In red, ripened fruits, only lower molecular weight S-specific subproducts (50 kDa) were detected in Fig. 2B Lower Right (lanes 1, 4, and 5 ). High expression levels of the 79-kDa S protein were detected in several Km R transgenic tobacco lines (Fig. 3C Right) . Additional protein bands were present in some extracts of transgenic and nontransgenic tobacco lines. The level of protein expression in tobacco roots was significantly higher than that in leaves.
Several of the highest S1 protein-expressing tobacco and tomato T 0 transgenic lines were taken through a plant-breeding scheme to generate homozygous lines to increase and genetically stabilize the high expression levels of S1 protein.
Km R T 1 tobacco lines (cv. LAMD-609) were grown hydroponically to obtain large amounts of root tissue (Fig. 3D Left) for immunological experiments. Western blot analysis of T 1 lines revealed high levels of S protein expression comparable with the original T 0 transgenic lines (Fig. 3D Right) .
Immune Response of Mice to Plant-Derived SARS-CoV 79-kDa S
Protein. Each BALB͞c mouse was fed with 500 mg of lyophilized tomato fruit containing the antigen and exhibited a significant increase in IgA levels in the fecal pellet extracts (Fig. 2C) . Samples showed no increased IgA levels in mice fed with nontransgenic fruit tissue and in the corresponding preimmune controls. No increase in IgG levels was detected in fecal extracts of transgenic fruit-fed mice or in corresponding sera of the same mice (data not shown). This experiment was limited by the quantity of transgenic tomato fruit material. In another experiment, mice were immunized orally and parenterally with lyophilized transgenic tobacco root tissue expressing the 79-kDa S1 protein. No increase in the level of S protein reactive antibodies was detected during the course of three immunizations with transgenic tobacco material given by either route; however, after a booster dose of S peptide, a significant increase of S protein-specific total IgG was detected in mice immunized parenterally (Fig. 4A, group II ϩ) , equal to a secondary immune response obtained with commercially obtained S peptides (Fig. 4A, group III) . No increase in IgG levels was detected in groups immunized parenterally with control plants or material administered by g.i. (Fig. 4A , group II Ϫ and group I). Sera from group II mice were further tested by Western blot analyses for the presence of SARS-CoV S protein-specific antibodies. Results are shown for sera of mice primed i.p. with plant material and boosted with S peptide (Fig. 4B Left) . Sera from those mice reacted with the 139-kDa commercial S protein (lane 1), the E. coli-expressed 79-kDa form and its subfragments (lane 2), and with commercial S peptide (lane 5). No reactivity with control protein extracts from E. coli was detected (lanes 3 and 4), and no reactivity was detected with any of the above proteins in sera of mice immunized with control plants and boosted with S peptide (Fig. 4B  Left Ϫ) . Polyclonal rabbit antibodies were used to confirm S protein specificity of the reactions (Fig. 4B Right) . As expected, Sm antibodies detected only the full-size S protein (lane 1) and the 79-kDa truncated S protein (lane 2), whereas Sn antibodies reacted with the 79-kDa truncated S protein and with the booster S peptide (lane 5). The expected reactivity with 53-kDa S protein was detectable but after a longer exposure.
Detailed analysis of Ig subclasses in sera of mice from group II and group III (Fig. 5) revealed an anti-S protein IgG1 immune response equal to that produced after double immunization with commercial S peptide in mice primed with plant material (Fig. 5A) . Levels of IgG2a and IgG2b in mice immunized with plant material were about one-half of those obtained during secondary immune response (Fig. 5 B and C) . No changes in serum IgG3, IgM, or IgA levels were detected, and no S protein-specific IgE antibodies were detected in any sera at dilutions starting at 1:2 (data not shown).
Discussion
An enormous effort has been made by the scientific community to develop a vaccine against SARS (12, 13, 18, 38, 39) . With the goal of generating a safe and inexpensive subunit vaccine that can be delivered by an oral route, we have chosen to produce the recombinant SARS antigen in transgenic plants. Recently, several groups have presented key data regarding the immunogenicity of different SARS proteins and have come to the conclusion that SARS-CoV S protein is the best candidate for recombinant vaccine development (12) (13) (14) (15) (16) (17) (18) (19) . Moreover, it was shown for other CoVs (swine transmissible gastroenteritis virus, infectious bronchitis virus, and porcine epidemic diarrhea virus) that plant-derived recombinant antigen in the form of the S protein could also induce strong protective immunity in animals (9) (10) (11) 32) . Based on these studies and others showing that the truncated version of the SARS-CoV S protein (S1) contains important antigenic domains (14, 25), we have selected this fragment for in planta expression. To ensure high accumulation and proper posttranslational modification of the glycoprotein, we assembled several expression cassettes with this transgene. One of the cassettes that combines plant SP and the endoplasmic reticulum retention signal (HDEL) (40) and is driven by the super promoter (33) has proved to be the best in the projected tissue-specific expression (fruits and roots) in transgenic plants.
Two plant species were chosen to express the SARS-CoV recombinant antigen: tomato and low-nicotine tobacco. Tomato is an easy-to-transform crop plant with abundant edible fruit tissue available for direct utilization and͞or downstream processing (41, 42) . Tobacco is an extremely efficient plant transformation system and is frequently used in plant biotechnology as the system of choice (27) (28) (29) . In this study, we explore the possibility of using a lownicotine tobacco variety that contains much less (0.06%) total nicotine (compared with 2-4% in other tobacco varieties).
After preliminary molecular characterization, the best transgenic plants were tested for the presence of recombinant S protein by Western blot analysis. This method makes possible a visual detection of recombinant protein in transgenic samples when it is expressed͞accumulated at high levels (Ͼ0.1% total soluble protein). We have obtained plant-derived antigen of correct size in several transgenic plants in adequate amounts to conduct immunological experiments. Some variations in size of recombinant protein were observed in mature and immature tissue of transgenic tomato. Presumably, this variation is due to proteolytic cleavage of the recombinant protein that occurs in the tissue of red, ripened tomato fruits.
The demonstration that S proteins of several CoVs (swine transmissible gastroenteritis virus, porcine epidemic diarrhea virus, and infectious bronchitis virus) are immunogenic when administered orally in animals (9) (10) (11) 32) led us to test plant-derived SARS antigen by this route. Indeed, mice showed a significant increase in mucosal IgA production after a single feeding, pointing to the feasibility of developing a plant-based oral vaccine against SARS. Using g.i. to deliver three doses of lyophilized tobacco root material followed by a boost did not produce detectable immune response in mice, in contrast with the results with direct tomato fruit feeding, where IgA levels were increased after a single dose. The possible explanation for these results might be the smaller amount of antigen present in tobacco root material and͞or the lower dose of plant material that was administered to mice. Another explanation could be a longer mucosal exposure to plant-derived antigen through the process of chewing, swallowing, etc., associated with tomato feeding, as compared with g.i. delivery of tobacco root material directly to the stomach.
The mice parenterally primed with plant-derived antigen developed an immune response after a booster immunization with N-terminal S protein peptide that by itself was not immunogenic without adjuvant. The fact that plant-derived material was not immunogenic by itself and required boosting immunization is not surprising. Similar results were demonstrated in several other studies. Boosting immunization was required for plant-expressed rabies G protein (43) , Tat protein from HIV-1 virus (44) , and S proteins from other CoVs (11). Lamphear et al. (11) reported swine feeding studies of oral swine transmissible gastroenteritis virus vaccine candidates to boost immunogenic responses in gilts previously sensitized with a commercially available, modified live viral vaccine. For human vaccines, some data suggested that plantderived vaccines may be used as boosting vaccines, after primary immunization with vaccines produced by more traditional technologies (45) . At the same time, a number of successful attempts to induce immune response with plant-expressed antigens without boosting immunization with vaccines produced by traditional methods have been reported (28) . Necessity of boosting immunization may be due to the quantity and nature of expressed antigen as well as usage of adjuvants.
The increased ratio of IgG1͞IgG2 in animals injected with plant-derived S protein, compared with the secondary immune response to purified S peptide, suggests a shift toward a Th2-type response in animals primed with the plant-derived material (46) . The type of immune response is known to be important in achieving maximum protection against various pathogens (47, 48) . However, at present, the available data are insufficient to allow conclusions about the requirements for an optimal immune response against SARS-CoV.
In sum, our study demonstrates the successful expression of SARS-CoV S protein in transgenic plants in amounts sufficient to induce antibody response after feeding mice with transgenic material. The mice parenterally primed with plant-derived antigen developed an immune response after a booster immunization. Progress toward the goal of establishing a safe and inexpensive vaccination program awaits further study with other animals and optimization of feeding protocols that might include, for example, oral administration of subunit vaccine expressed in tomato fruit followed by a boost with tobacco-derived antigen.
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